Хайлтын үр дүнгүүд - Vimal Mehta
- 2-н 1 - 2 үр дүнгүүдийг харуулж байна
-
1
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial -н Frederick J. Raal, Nyda Fourie, Russell Scott, Dirk Blom, Matthys De Vries Basson, Meral Kayıkçıoğlu, Kate Caldwell, David Kallend, Evan A. Stein, Traci Turner, Jean Bergeron, Artuela Çaku, Avishay Elis, Ronen Durst, Zafer Yalım, Meral Kayıkçıoğlu, Bahadır Kırılmaz, Ataç Çelik, Irfan Duzen, Abdurraham Oguzhan, İbrahim Başarıcı, Frederick J. Raal, Dirk Blom, M Abelson, Matthys M de V Basson, Lesley Burgess, Nyda Fourie, Eli Heggen, Emil Andreas Asprusten, Vimal Mehta, Raman Puri, Ashwani Mehta, Preeti Gupta, Milan Chag, Akshyaya Pradhan, Francisco Fuentes, Fernando Civeira Murillo, Xavier Pintó, Russell Scott
Хэвлэсэн 2023Artigo -
2
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV -н Raman Puri, Manish Bansal, Vimal Mehta, P. Barton Duell, Nathan D. Wong, SS Iyengar, Dinesh Kalra, Devaki Nair, Navin C. Nanda, Jagat Narula, Prakash Deedwania, Jamal Yusuf, Jamshed Dalal, Sadanand Shetty, Vinod Vijan, Rajeev Agarwala, Soumitra Kumar, Kris Vijay, Aziz Khan, Gurpreet Singh Wander, PC Manoria, SK Wangnoo, Viswanathan Mohan, Shashank Joshi, Balbir Singh, Prafulla Kerkar, Rajesh Rajput, D Prabhakar, Abdul Hamid Zargar, Banshi Saboo, Ravi R. Kasliwal, Saumitra Ray, Sandeep Bansal, MU Rabbani, Shibba Takkar Chhabra, Sarat P. Chandra, Neil Bardoloi, Narasaraju Kavalipati, I Sathyamurthy, Kunal Mahajan, Akshya Pradhan, NN Khanna, Rajesh Khadgawat, Preeti Gupta, Milan Chag, Ashu Gupta, A. Murugnathan, S N Narasingan, Sundeep Kumar Upadhyaya, Vinod Mittal, Rashida Patanwala Melinkeri, Madhur Yadav, Mohamed Mubarak, K K Pareek, Pradeep Kumar Dabla, Rashmi Nanda, JC Mohan
Хэвлэсэн 2024Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Adverse effect
Alternative medicine
Atherosclerotic cardiovascular disease
Cholesterol
Computer science
Computer security
Confidence interval
Disease
Dosing
Dyslipidemia
Endocrinology
Familial hypercholesterolemia
Family medicine
Gastroenterology
Intensive care medicine
Kexin
LDL receptor
Lipoprotein
PCSK9
Pathology
Placebo
Psychiatry
Psychological intervention
Randomized controlled trial
Risk assessment
Subclinical infection
Urology